VIFOR PHARMA, INC.
KING OF PRUSSIA, PA


RELYPSA, INC.
VIFOR PHARMA, INC. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of polymer-based medicines designed to address often overlooked or undertreated medical conditions with serious impacts on patient lives or potential to be life-threatening. Following its foundation in October 2007, Relypsa became an integral part of VIFOR Pharma in September 2016, enhancing their focus on developing transformative treatments. Headquartered in Redwood City, California, the company has expanded its operations under the parent group known as Vifor Fresenius Medical Care Renal Pharma. In recent developments, Vifor Pharma has undertaken strategic steps including initiating the Submission of a Marketing Authorisation Application in Europe for Patiromer to treat hyperkalemia and signing an acquisition agreement with Soho Flordis International. Additionally, they have expanded their product portfolio and established marketing and sales organization within Europe. Previously known as Relypsa, Inc., the company continues to uphold a mission of innovation within the pharmaceutical domain, underlined by regulatory compliance, evidenced by its filing status as FORP with a Florida Corporate Identification number F15000005435. The last amendment event was recorded on March 2, 2021, and its annual reports are filed up to the year 2024. VIFOR PHARMA, INC. maintains open channels for medical information, drug safety concerns, adverse event reporting, and product quality complaints. With operations at 200 Cardinal Way, Redwood City, CA, Vifor Pharma can be contacted via multiple phone lines: (650) 421-9500, (844) 735-9772, and (844) 835-8277, facilitating engagement with stakeholders both professionally and medically. The company's leadership includes key figures such as Matthew Bocchino serving as Treasurer, Timothy Kanter as Vice President, and Alex Sigalas managing Secretarial duties. Vifor Pharma remains committed to enhancing patient outcomes through innovative medical solutions and strategic corporate growth.

KEY FACTS ABOUT VIFOR PHARMA, INC.

Company name
VIFOR PHARMA, INC.
Status
Active
Filed Number
F15000005435
FEI Number
26-0893742
Date of Incorporation
December 9, 2015
Age - 10 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://relypsa.com
Phones
(650) 421-9500
(844) 735-9772
(844) 835-8277

VIFOR PHARMA, INC. NEAR ME

Principal Address
1000 First Ave,
Suite 300,
King of Prussia,
PA,
19406,
US

See Also

Officers and Directors

The VIFOR PHARMA, INC. managed by the three persons from King of Prussia, Glattbrugg on following positions: Trea, Vice President, Secr

Matthew Bocchino

Position
Trea Active
From
King of Prussia, PA, PA

Timothy Kanter

Position
Vice President Active
From
King of Prussia, PA, PA

Alex Sigalas

Position
Secr Active
From
Glattbrugg, Gl, Gl





Registered Agent is CT CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Events

March 2, 2021
AMENDMENT AND NAME CHANGE

Annual Reports

2025
March 28, 2025
2024
April 19, 2024